Search hospitals > Illinois > Normal
Community Cancer Center
Claim this profileNormal, Illinois 61761
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
225 reported clinical trials
7 medical researchers
Summary
Community Cancer Center is a medical facility located in Normal, Illinois. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Leukemia, Lymphoma and other specialties. Community Cancer Center is involved with conducting 225 clinical trials across 230 conditions. There are 7 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Pratima Chalasani.Area of expertise
1Breast Cancer
Global LeaderStage III
ER positive
Stage IV
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Vamsi K. VasireddyCarle Cancer Center2 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
30 reported clinical trials
55 drugs studied
Maria T. Grosse-PerdekampCarle Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
29 reported clinical trials
60 drugs studied
Suparna ManthaCarle Cancer Center4 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
29 reported clinical trials
64 drugs studied
Pratima ChalasaniCarle Cancer Center1 year of reported clinical research
Expert in Cancer
Expert in Breast Cancer
23 reported clinical trials
42 drugs studied
Clinical Trials running at Community Cancer Center
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Cancer
Esophageal Adenocarcinoma
Pancreatic Cancer
Thyroid Cancer
Breast Cancer
Tumors
Colorectal Cancer
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Community Cancer Center?
Community Cancer Center is a medical facility located in Normal, Illinois. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Leukemia, Lymphoma and other specialties. Community Cancer Center is involved with conducting 225 clinical trials across 230 conditions. There are 7 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Pratima Chalasani.